FDA Notices of Judgment Collection, 1908-1966

Search

Start Over Titles 775. Adulteration and misbranding of sodium cacodylate solution, alkaline compound powder, calcium gluconate compound solution, diuretic powder canine worm tablets, liquid nux vomica alkaloids, and tonic powder; and misbranding of Aresnol Compound Powder, glucose solution, potassium arsenite compound tablets, santonin-calomel tablets, Gualadine Tablets, Conjunctivities #1 Tablets, and tetrachlorethylene capsules. U. S. v. Peerles Serum Co. Plea of guilty. Fine, $105 and costs. ✖Remove constraint Titles: 775. Adulteration and misbranding of sodium cacodylate solution, alkaline compound powder, calcium gluconate compound solution, diuretic powder canine worm tablets, liquid nux vomica alkaloids, and tonic powder; and misbranding of Aresnol Compound Powder, glucose solution, potassium arsenite compound tablets, santonin-calomel tablets, Gualadine Tablets, Conjunctivities #1 Tablets, and tetrachlorethylene capsules. U. S. v. Peerles Serum Co. Plea of guilty. Fine, $105 and costs. Issue Dates September 1943 ✖Remove constraint Issue Dates: September 1943 Adjudicating Courts District of Kansas ✖Remove constraint Adjudicating Courts: District of Kansas

Refine by:

  • 775. Adulteration and misbranding of sodium cacodylate solution, alkaline compound powder, calcium gluconate compound solution, diuretic powder canine worm tablets, liquid nux vomica alkaloids, and tonic powder; and misbranding of Aresnol Compound Powder, glucose solution, potassium arsenite compound tablets, santonin-calomel tablets, Gualadine Tablets, Conjunctivities #1 Tablets, and tetrachlorethylene capsules. U. S. v. Peerles Serum Co. Plea of guilty. Fine, $105 and costs.1